This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Biohaven Therapeutics Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David K. Leahy - Innovator in Immunology
Introduction
David K. Leahy is an accomplished inventor based in Marblehead, MA (US). He is currently associated with Bristol-Myers Squibb Company, where he contributes to advancements in the field of immunology. Although he does not hold any granted patents, his work is significant in the development of innovative therapeutic solutions.
Latest Patent Applications
David K. Leahy has submitted a notable patent application titled "Bifunctional Degraders of Galactose-Deficient Immunoglobulins." This application describes a composition of matter that includes a deglycosylated IgA-binding moiety and a cellular receptor-binding moiety. The composition is designed to bind to hepatocytes or other degrading cells through asialoglycoprotein receptors (ASGPR) on their surface. This innovative approach aims to remove galactose-deficient IgA1 in patients, showcasing the potential for significant therapeutic impact.
Conclusion
David K. Leahy's contributions to immunology through his patent application reflect his commitment to advancing medical science. His work at Bristol-Myers Squibb Company highlights the importance of innovation in developing new treatments for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile